Funding for this research was provided by:
Bayerisches Staatsministerium für Wissenschaft und Kunst
Received: 27 December 2022
Accepted: 15 March 2023
First Online: 24 March 2023
: The study involving human participants was reviewed and approved by the ethics committee of the Medical Faculty of the Ludwig-Maximilians-University (LMU) Munich, Germany (Ref. 20–1084) and was performed in accordance with the ethical standards as defined in the Declaration of Helsinki. The participants provided their written informed consent to participate in this study.
: Not applicable.
: All authors report no conflicts of interest regarding the scope of this work. AH has received paid speakerships from Janssen, Otsuka, Rovi, Recordati, Advanz and AbbVie. He was member of Rovi, Recordati, Otsuka, Lundbeck, and Janssen advisory boards. All other authors declare that they have no competing interests.